Mutated SARS-CoV-2 could be more susceptible to vaccines

Written by Jenny Straiton

SARS-CoV-2 mutation

A mutation in the genome of SARS-CoV-2 enabled it to spread around the world at a rapid pace, but new research suggests that same mutation could increase the virus’ susceptibility to a vaccine. New research from the University of North Carolina at Chapel Hill and the University of Wisconsin-Madison (USA) has suggested that a new strain of SARS-CoV-2 – named D614G – that emerged in Europe and is currently the most common strain in the world may be more susceptible to a vaccine than previous strains of the COVID-19-causing virus. In animal studies investigating this latest strain of the virus,...

To view this content, please register now for access

Become a member of BioTechniques for FREE to receive:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!